BEHANDLUNG VON MULTIPLER SKLEROSE (MS) MIT CAMPATH-1H

Patent europeic · EP3028718 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3028718
Numer da la dumonda
EP15191491
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
11-09-2007
Publitgà
08-06-2016
Concedì
23-03-2022
La protecziun finescha il pli tard
10-09-2027
Proxima taxa annuala scadenta
30-09-2027
Classas IPC
A61K 39/395 (2006.01)
C07K 16/28 (2006.01)
Prioritad
US 844251 P 13.09.2006
EP 06090169 14.09.2006
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-10-2026

    Next annual fee due on

    Next annual fee due on
    30.09.2026 → 30.09.2027

    Published in Swissreg on 01.10.2026

  2. 01-10-2025

    Next annual fee due on

    Next annual fee due on
    30.09.2025 → 30.09.2026

    Published in Swissreg on 01.10.2025

  3. 03-10-2024

    Midada

    Published in Swissreg on 03.10.2024

  4. 01-10-2023

    Midada

    Published in Swissreg on 01.10.2023

  5. 17-02-2023

    Midada

    Published in Swissreg on 17.02.2023

  6. 01-02-2023

    Midada

    Published in Swissreg on 01.02.2023

  7. 23-03-2022

    Concedì

    Published in Swissreg on 23.03.2022

Partidas

Possessur

Genzyme Corporation

50 Binney Street, Cambridge, MA 02142, US

Alcafleu Management GmbH & Co. KG

Lilienthalstrasse 4, 12529 Schönefeld OT Waltersdorf, DE

Inventur

SACHSE, Andreas

10709 Berlin, DE

MARGOLIN, David Harris

Sommerville, MA 02144, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.